HERON THERAPEUTICS INC's ticker is HRTX and the CUSIP is 427746102. A total of 69 filers reported holding HERON THERAPEUTICS INC in Q1 2015. The put-call ratio across all filers is 0.02 and the average weighting 0.7%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $1,201,970 | +1044.7% | 480,788 | +1831.0% | 0.01% | +700.0% |
| Q3 2022 | $105,000 | +123.4% | 24,899 | +47.4% | 0.00% | – |
| Q2 2022 | $47,000 | -39.0% | 16,888 | +24.7% | 0.00% | – |
| Q1 2022 | $77,000 | -90.8% | 13,547 | -85.2% | 0.00% | -100.0% |
| Q4 2021 | $837,000 | -84.2% | 91,680 | -81.5% | 0.00% | -85.7% |
| Q3 2021 | $5,305,000 | -31.1% | 496,283 | -0.0% | 0.03% | -31.7% |
| Q2 2021 | $7,704,000 | -6.4% | 496,416 | -2.2% | 0.04% | -10.9% |
| Q1 2021 | $8,228,000 | -24.8% | 507,586 | -1.8% | 0.05% | -29.2% |
| Q4 2020 | $10,939,000 | +39.9% | 516,852 | -2.0% | 0.06% | +32.7% |
| Q3 2020 | $7,818,000 | +24.1% | 527,563 | +23.2% | 0.05% | +22.5% |
| Q2 2020 | $6,300,000 | +78.4% | 428,268 | +42.4% | 0.04% | +60.0% |
| Q1 2020 | $3,531,000 | +66.2% | 300,764 | +232.8% | 0.02% | +150.0% |
| Q4 2019 | $2,124,000 | -41.4% | 90,380 | -53.8% | 0.01% | -41.2% |
| Q3 2019 | $3,623,000 | -70.0% | 195,832 | -69.9% | 0.02% | -68.5% |
| Q2 2019 | $12,083,000 | -12.8% | 650,008 | +14.7% | 0.05% | -12.9% |
| Q1 2019 | $13,849,000 | +13.4% | 566,656 | +20.3% | 0.06% | +8.8% |
| Q4 2018 | $12,214,000 | +2.5% | 470,872 | +25.0% | 0.06% | +26.7% |
| Q3 2018 | $11,919,000 | -15.4% | 376,619 | +3.9% | 0.04% | -19.6% |
| Q2 2018 | $14,082,000 | +31.7% | 362,476 | -6.5% | 0.06% | +33.3% |
| Q1 2018 | $10,695,000 | +64.5% | 387,503 | +7.9% | 0.04% | +75.0% |
| Q4 2017 | $6,501,000 | +8.6% | 359,155 | -3.1% | 0.02% | 0.0% |
| Q3 2017 | $5,988,000 | +9.1% | 370,759 | -6.4% | 0.02% | +9.1% |
| Q2 2017 | $5,488,000 | -17.3% | 396,256 | -10.4% | 0.02% | -21.4% |
| Q1 2017 | $6,633,000 | +84.8% | 442,175 | +61.4% | 0.03% | +75.0% |
| Q4 2016 | $3,589,000 | +3.3% | 273,973 | +35.9% | 0.02% | -5.9% |
| Q3 2016 | $3,475,000 | -26.3% | 201,657 | -22.8% | 0.02% | -26.1% |
| Q2 2016 | $4,716,000 | +1.2% | 261,298 | +6.5% | 0.02% | 0.0% |
| Q1 2016 | $4,660,000 | +35.4% | 245,392 | +90.3% | 0.02% | +35.3% |
| Q4 2015 | $3,442,000 | +64.3% | 128,931 | +50.2% | 0.02% | +54.5% |
| Q3 2015 | $2,095,000 | -9.8% | 85,859 | +15.2% | 0.01% | -8.3% |
| Q2 2015 | $2,322,000 | +1991.9% | 74,517 | +879.2% | 0.01% | +1100.0% |
| Q1 2015 | $111,000 | – | 7,610 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TANG KEVIN C | 760 | $1,900 | 100.00% |
| Velan Capital Investment Management LP | 2,500,000 | $6,250,000 | 5.52% |
| GREAT POINT PARTNERS LLC | 6,360,161 | $15,900,403 | 3.12% |
| Cheyne Capital Management (UK) LLP | 318,008 | $795,020 | 1.39% |
| TANG CAPITAL MANAGEMENT LLC | 3,755,934 | $9,389,835 | 1.36% |
| Rubric Capital Management LP | 11,750,000 | $29,375,000 | 1.28% |
| Orchard Capital Management, LLC | 1,391,080 | $3,477,700 | 1.17% |
| JACOB ASSET MANAGEMENT OF NEW YORK LLC | 267,028 | $667,570 | 0.81% |
| CM Management, LLC | 250,000 | $625 | 0.75% |
| Tejara Capital Ltd | 493,619 | $1,234,048 | 0.71% |